Benralizumab for the treatment of asthma-Reference-Cited by-同舟云学术

Benralizumab for the treatment of asthma

Published:2017-04-19 Issue:5 Volume:13 Page:405-413
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Saco Tara Vinyette¹,Pepper Amber N.¹,Lockey Richard F.¹

Affiliation:

1. Division of Allergy and Immunology, Department of Internal Medicine, University of South Florida Morsani College of Medicine and James A. Haley Veterans Affairs Medical Center, Tampa, FL, USA

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2017.1316194

Reference43 articles.

1. Characterization of asthma endotypes: implications for therapy

2. Benralizumab: a unique IL-5 inhibitor for severe asthma

3. An update on biologic-based therapy in asthma

4. Biologic therapy for atopic asthma and beyond

5. Anti-Interleukin Therapy in Asthma

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of nano- and micro-particle-based approaches for selected bronchodilators in management of asthma;3 Biotech;2024-08-23

2. Current and Novel Biologic Therapies for Patients with Asthma and Nasal Polyps;Otolaryngologic Clinics of North America;2023-09

3. From Biomarkers to Novel Therapeutic Approaches in Chronic Obstructive Pulmonary Disease;Biomedicines;2021-11-08

4. JAK Family Inhibitors for Autoimmune Diseases;Burger's Medicinal Chemistry and Drug Discovery;2021-04-28

5. Changes in Serum MicroRNAs after Anti-IL-5 Biological Treatment of Severe Asthma;International Journal of Molecular Sciences;2021-03-30